In addition, a clinical study showed lower expression of soluble receptors for advanced glycation end products (sRAGE), as well as higher levels of β-secretase enzyme (BACE1) and neprilysin (NEP) in dementia patients (79). The gene discussed is MME; the disease is dementia.